메뉴 건너뛰기




Volumn 29, Issue 18, 2011, Pages

Successful treatment of relapsed and refractory extramedullary acute promyelocytic leukemia with tamibarotene

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; BUSULFAN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; GEMTUZUMAB OZOGAMICIN; IDARUBICIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; PROMYELOCYTIC LEUKEMIA PROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; TAMIBAROTENE;

EID: 79959289081     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.34.8953     Document Type: Article
Times cited : (11)

References (10)
  • 1
    • 77953352154 scopus 로고    scopus 로고
    • Unusual presentation of myeloid sarcoma in a case of acute promyelocytic leukemia with a cryptic PML-RARA rearrangement involving multiple sites including the atrium
    • Tirado CA, Chen W, Valdez F, et al: Unusual presentation of myeloid sarcoma in a case of acute promyelocytic leukemia with a cryptic PML-RARA rearrangement involving multiple sites including the atrium. Cancer Genet Cytogenet 200:47-53, 2010
    • (2010) Cancer Genet Cytogenet , vol.200 , pp. 47-53
    • Tirado, C.A.1    Chen, W.2    Valdez, F.3
  • 2
    • 33845226015 scopus 로고    scopus 로고
    • Identification of PML-RARA rearrangement by RT-PCR and sequencing in an acute promyelocytic leukemia without t(15;17) on G-banding and FISH
    • Han JY, Kim KE, Kim KH, et al: Identification of PML-RARA rearrangement by RT-PCR and sequencing in an acute promyelocytic leukemia without t(15;17) on G-banding and FISH. Leuk Res 31:239-243, 2007
    • (2007) Leuk Res , vol.31 , pp. 239-243
    • Han, J.Y.1    Kim, K.E.2    Kim, K.H.3
  • 3
    • 62549083523 scopus 로고    scopus 로고
    • Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia
    • Hu J, Liu YF, Wu CF, et al: Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia. Proc Natl Acad Sci U S A 106:3342-3347, 2009
    • (2009) Proc Natl Acad Sci U S A , vol.106 , pp. 3342-3347
    • Hu, J.1    Liu, Y.F.2    Wu, C.F.3
  • 4
    • 33644976445 scopus 로고    scopus 로고
    • Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy
    • de Botton S, Sanz MA, Chevret S, et al: Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Leukemia 20:35-41, 2006
    • (2006) Leukemia , vol.20 , pp. 35-41
    • De Botton, S.1    Sanz, M.A.2    Chevret, S.3
  • 5
    • 33846499100 scopus 로고    scopus 로고
    • Extramedullary disease and targeted therapies for hematological malignancies-is the association real?
    • Raanani P, Shpilberg O, Ben-Bassat I: Extramedullary disease and targeted therapies for hematological malignancies-is the association real? Ann Oncol 18:7-12, 2007
    • (2007) Ann Oncol , vol.18 , pp. 7-12
    • Raanani, P.1    Shpilberg, O.2    Ben-Bassat, I.3
  • 6
    • 79951870169 scopus 로고    scopus 로고
    • Isolated bowel relapse in acute promyelocytic leukemia: An unusual site of extramedullary recurrence
    • Ochs RC, Gormley RH, Luger S, et al: Isolated bowel relapse in acute promyelocytic leukemia: An unusual site of extramedullary recurrence. J Clin Oncol 28:e550-553, 2010
    • (2010) J Clin Oncol , vol.28
    • Ochs, R.C.1    Gormley, R.H.2    Luger, S.3
  • 7
    • 0027448677 scopus 로고
    • Retinoid resistance in acute promyelocytic leukemia: New mechanisms, strategies, and implications
    • Warrell RP Jr: Retinoid resistance in acute promyelocytic leukemia: New mechanisms, strategies, and implications. Blood 82:1949-1953, 1993
    • (1993) Blood , vol.82 , pp. 1949-1953
    • Warrell Jr., R.P.1
  • 8
    • 0030992905 scopus 로고    scopus 로고
    • A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RARalpha mutation
    • Shao W, Benedetti L, Lamph WW, et al: A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RAR alpha mutation. Blood 89:4282-4289, 1997 (Pubitemid 27260235)
    • (1997) Blood , vol.89 , Issue.12 , pp. 4282-4289
    • Shao, W.1    Benedetti, L.2    Lamph, W.W.3    Nervi, C.4    Miller Jr., W.H.5
  • 9
    • 77956803066 scopus 로고    scopus 로고
    • Molecular remission in advanced acute promyelocytic leukaemia after treatment with the oral synthetic retinoid Tamibarotene
    • Di Veroli A, Ramadan SM, Divona M, et al: Molecular remission in advanced acute promyelocytic leukaemia after treatment with the oral synthetic retinoid Tamibarotene. Br J Haematol 151:99-101, 2010
    • (2010) Br J Haematol , vol.151 , pp. 99-101
    • Di Veroli, A.1    Ramadan, S.M.2    Divona, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.